ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
0.8014
-0.0483 (-5.68%)
At close: May 16, 2025, 4:00 PM
0.8066
+0.0052 (0.65%)
After-hours: May 16, 2025, 4:05 PM EDT
ProKidney Stock Forecast
PROK's stock price has decreased by -79.56% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for ProKidney stock ranges from a low of $3.00 to a high of $6.00. The average analyst price target of $5.00 forecasts a 523.91% increase in the stock price over the next year.
Price Target: $5.00 (+523.91%)
Analyst Consensus: Buy
* Price targets were last updated on Sep 10, 2024.
Analyst Ratings
The average analyst rating for ProKidney stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 30, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +648.69% | Sep 10, 2024 |
B of A Securities | B of A Securities | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +274.34% | Sep 4, 2024 |
Jefferies | Jefferies | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +648.69% | Jun 10, 2024 |
B of A Securities | B of A Securities | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +399.13% | May 29, 2024 |
Financial Forecast
Revenue This Year
n/a
from 76.00K
Revenue Next Year
n/a
EPS This Year
-0.61
from -0.62
EPS Next Year
-0.61
from -0.61
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.55 | -0.48 | -0.49 | ||
Avg | -0.61 | -0.61 | -0.70 | ||
Low | -0.71 | -0.80 | -0.80 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.